Conditions: Allergic Conjunctivitis
Enrollment: 87

Brief summary:
The purpose of the study is to demonstrate safety and efficacy of DE-114 ophthalmic solution compared to its Placebo and Olopatadine hydrochloride 0.1% ophthalmic solution in patients with allergic conjunctivitis.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: DE-114 ophthalmic solution intervention 2: Placebo ophthalmic solution intervention 3: Olopatadine Hydrochloride 0.1% Ophthalmic Solution
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: